Article PDF first page preview

First page of Comparison of Flexible-Tip and Non-Flexible Ureteral Access Sheaths for Treatment of Renal Lower Calyx Stones

Introduction: To compare the efficacy of a flexible-tip ureteral access sheath (F-UAS) with a traditional non-flexible ureteral access sheath (T-UAS) in the treatment of renal lower calyx stones. Methods: This retrospective analysis included clinical data from patients with unilateral renal lower calyx stones who underwent treatment with either a f-UAS (cases from December 2023 to September 2024) or a T-UAS (cases from January 2023 to November 2023). Inclusion criteria were ages 18-75 years, lower pole kidney stones measuring 1-2 cm. The primary outcome was the immediate postoperative stone-free rate (SFR) on the first day post-surgery. Secondary outcomes included operative time, postoperative complications, postoperative hospital stay, and three-month SFR. Results: A total of 132 patients were included in the study, with 63 in the F-UAS group and 69 in the T-UAS group. Baseline characteristics were comparable between groups. The F-UAS group demonstrated a significantly higher day-1 postoperative SFR (73.0% vs. 17.4%; P < 0.001). The overall complication rate was lower in the F-UAS group (P = 0.031), with a notably reduced incidence of postoperative fever. The F-UAS group also had a significantly lower basket usage rate (20.6% vs. 100%; P < 0.001). There were no significant differences in operative time or three-month SFR between the groups (P = 0.097 and P = 0.354, respectively). Hospital stay and stone composition were also similar between groups. Conclusion: Compared to T-UAS, the use of F-UAS for retrograde intrarenal surgery in the treatment of renal lower calyx stones is associated with a higher day-1 SFR. Additionally, the F-UAS group demonstrated reduced basket usage and fewer postoperative complications.

Journal Section:
Research Article
This content is only available via PDF.
S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.